Is Nasdaq- and JSE-listed Montauk Renewables worth a look?

Loading player...
Deryck Janse van Rensburg of Anchor Capital on Montauk Renewables as it expands in the US, and whether Life Healthcare or Netcare offer value as Mediclinic's delisting is approved. Stian de Witt from NMG Benefits on using tax incentives to save and earn more. Debtsource's Frank Knight on changes to laws around theh FATF greylisting.
27 Mar 2023 1AM English South Africa Business News · Business

Other recent episodes

Cell C results: Is the value proposition compelling?

Analysis of Cell C’s latest results as the stock trades just below its November IPO price, and a look at how a tough decision taken by Richemont a decade ago is paying dividends in today’s share price.
24 Aug 1AM 22 min

Spur with a taste for dividends

Analysis of Spur’s strong results against a tougher performance from Exxaro and the opportunities that shifting market regimes are creating for active investors.
21 Aug 1AM 19 min